Отправить статью по E-mail Conjugates of Prostate-Specific Membrane Antigen Ligands with Antitumor Drugs
- Авторы: Uspenskaya A.A.1, Machulkin A.É.1, Mazhuga A.G.1,2, Beloglazkina E.K.1
-
Учреждения:
- Department of Chemistry, M. V. Lomonosov Moscow State University
- D. Mendeleev University of Chemical Technology of Russia
- Выпуск: Том 53, № 4 (2019)
- Страницы: 288-297
- Раздел: Article
- URL: https://ogarev-online.ru/0091-150X/article/view/245738
- DOI: https://doi.org/10.1007/s11094-019-01994-1
- ID: 245738
Цитировать
Открытый доступ
Доступ предоставлен
Только для подписчиков
Аннотация
Conjugates for targeted delivery that are based on low-molecular-mass prostate specific membrane antigen (PSMA) inhibitors are widely used and developed because of the deficiencies of existing methods for treating and diagnosing prostate cancer. The major classes of low-molecular-mass PSMA inhibitors, drug classes, and their mechanisms of action are discussed. Therapeutic conjugates for targeted delivery that are based on them are analyzed. Structural features of the linker that affect the biological activity and selectivity are identified.
Ключевые слова
Об авторах
A. Uspenskaya
Department of Chemistry, M. V. Lomonosov Moscow State University
Автор, ответственный за переписку.
Email: uspenskaya.n@gmail.com
Россия, GSP-1, Moscow, 199991
A. Machulkin
Department of Chemistry, M. V. Lomonosov Moscow State University
Email: uspenskaya.n@gmail.com
Россия, GSP-1, Moscow, 199991
A. Mazhuga
Department of Chemistry, M. V. Lomonosov Moscow State University; D. Mendeleev University of Chemical Technology of Russia
Email: uspenskaya.n@gmail.com
Россия, GSP-1, Moscow, 199991; Moscow, 125047
E. Beloglazkina
Department of Chemistry, M. V. Lomonosov Moscow State University
Email: uspenskaya.n@gmail.com
Россия, GSP-1, Moscow, 199991
Дополнительные файлы
